Abstract: Application of Model Based Drug Substance Particle Size Control in Drug Product Development (2010 Annual Meeting)

Mark Schrad¹, Jon Hilden¹, Jessica T. Sloan¹ and Jennifer Kuehne-Willmore², (1)Formulation and Process Development, Eli Lilly and Company, Indianapolis, IN, (2)Chemical Process Engineering, Eli Lilly and Company, Indianapolis, IN

TBD - pending legal approval

Extended Abstract: File Not Uploaded

See more of this Session: Model Based Integrated Design of Pharmaceutical Drug Product and Process
See more of this Group/Topical: Topical i : Comprehensive Quality by Design in Pharmaceutical Development and Manufacture